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A report on the 3rd UK Stem Cell Meeting ‘Epigenetics &
Differentiation’, London, UK, 11 March 2008.
Uncovering the foundations of the self-renewing capacity of
stem cells and their ability to give rise to multiple cell types
holds tremendous promise for understanding the basic
principles of eukaryotic development, cell differentiation
and genome reprogramming. Epigenetic mechanisms that
affect chromatin organization play a fundamental role in
these processes by controlling accessibility of the genome at
the right time and right place. A recent stem-cell meeting in
London provided a welcome opportunity to hear the latest
advances on the fundamental determinants of stem-cell fates
with an emphasis on epigenetic regulation in the mouse. The
highlights selected here focus on the extent to which
epigenetic mechanisms impact on stem-cell and develop-
mental biology and on the underlying molecular machinery.
E Ep pi ig ge en ne et ti ic c   c ch ha an ng ge es s   a as ss so oc ci ia at te ed d   w wi it th h   t th he e   d de ec ci is si io on n   t to o
d di if ff fe er re en nt ti ia at te e
One challenge is the quest for chromatin signatures
indicative of the developmental potential of a cell. This
major task is being tackled by large-scale profiling of
epigenetic modifications within the genomes of stem-cell
populations that have broad developmental plasticity and
the lineage-committed cells derived from them. Alexander
Meissner (Harvard University, Boston, USA) presented a
compelling technological advance enabling the analysis and
comparison of global DNA methylation patterns in a high-
throughput manner and, what is more, at nucleotide reso-
lution. The power of this approach comes from bisulfite
treatment of DNA, which converts all unmethylated cyto-
sines to uracil, coupled with Solexa next-generation DNA
sequencing technology. DNA fragments from, for example,
restriction digests, are selected by size, generating a ‘reduced
representation’ of the genome of a cell type or tissue.
Libraries of bisulfite-converted DNA fragments can be
compared to the same fraction of the genome across
different samples, such as preparations from distinct
developmental stages. Meissner and colleagues examined
the dynamics of DNA methylation as mouse embryonic stem
cells (ES cells) progress to neural precursors and neurons in
vitro. Intriguingly, very little change was found in the overall
distribution of DNA methylation between pluripotent cells
and their differentiated derivatives. The alterations observed
occurred primarily at CpG-poor promoters, which under-
went dynamic methylation and demethylation. Similarly,
distal regulatory regions of the transcription factors Olig1
and Olig2 became unmethylated upon their expression
during cellular differentiation. This contrasts with CpG-rich
promoters, most of which remain constitutively un-
methylated throughout differentiation.
The histone proteins in chromatin are covalently modified at
many sites, which affects chromatin activity and genome
regulation. Meissner observed a strong correlation between
levels of DNA and histone methylation under all develop-
mental conditions analyzed and independent of the
sequence context. Gain of tri-methylation of histone 3 at
lysine 4 (H3K4me3), a mark indicative of active chromatin,
correlated with DNA demethylation, whereas loss of
H3K4me3 correlated with DNA methylation. Further dissec-
tion of the relationship between DNA methylation and
different chromatin modifications during cellular differen-
tiation should help to clarify how these marks integrate a
wide range of signals that impact on chromatin function and
how they contribute to the regulatory networks that underlie
stem-cell fates. In this context, Angela Bithell (King’s College
London, UK) reported that neuronal stem cells and
astrocytes differentiated from them have a common histone
modification profile despite being transcriptionally distinct.
She suggested that this is a reflection of the fact that astro-
cytes retain multipotency.
A paradigm for chromosome-wide epigenetic gene regula-
tion during development is X-chromosome inactivation in
female mammals. X inactivation involves the interplay
between the cis-acting noncoding RNA Xist, changes in thehistone complement, and covalent modifications of DNA
and histones. Bryan Turner (University of Birmingham, UK)
described results consistent with a model whereby silencing
of the X chromosome occurs progressively in differentiating
ES cells, with different groups of genes becoming inactivated
at different stages of differentiation. He proposed that this is
linked to the configuration of the X-chromosome territory
and the progressive spreading of Xist RNA through this
territory. Turner also posed the question of how the male
mammal survives with only one X chromosome, given that
monosomy for autosomes is lethal in humans. Global
expression profiling on the mouse X chromosome using
microarrays provided a clue; in both males and females the
expression of X-linked genes is increased about twofold on
active X chromosomes relative to autosomes. Expression
levels of X-linked and autosomal genes are thus balanced in
mammalian genomes.
Neil Brockdorff (University of Oxford, UK) discussed mono-
ubiquitylation of histone 2A at lysine 119, which is mediated
by the Polycomb repressor complex 1 protein Ring1 and
occurs on the inactive X chromosome as well as genome-
wide. He reported that the RING-finger protein Mel-18
played a role in directing the repressor complex to nucleo-
somes. Interestingly, phosphorylation of Mel-18 is required
for ubiquitylation of nucleosomes but does not affect the
enzymatic activity per se: rather, it promotes recognition of
the substrate. Brockdorff proposed that reversible protein
phosphorylation of Polycomb complexes may regulate their
binding and/or their activity, conceivably by causing
conformational changes. Incorporation of ubiquitylated H2A
into chromatin inhibits transcription in a reconstituted
transcription assay in vitro, suggesting that this bulky
modification on lysine 119 can affect transcription directly.
This is in contrast to other histone modifications, which
frequently function as protein-binding modules.
A fascinating question is which chromatin features have an
impact on the first cell-fate decisions in the developing
embryo. Previous work has implicated histone marks in this
process. Maria Elena Torres-Padilla (IGBMC, Strasbourg,
France) highlighted a critical role for monomethylation on
lysine 20 of H4 during early mammalian development. She
found that, in the mouse, the abundance of this histone
mark increases after fertilization. Loss of the enzyme
responsible, Pr-Set7, causes an arrest at the G2/M phase of
the cell cycle and leads to pre-implantation lethality.
R Re ep pr ro og gr ra am mm mi in ng g   o of f   t th he e   g ge en no om me e
Developmental plasticity lost during differentiation can be
reacquired by resetting the appropriate gene-expression pro-
grams, a process that is critically dependent on epigenetic
reprogramming. Jerome Jullien (University of Cambridge,
UK) has developed a system to follow the steps of nuclear
reprogramming to a pluripotent state in real time. He
injected mammalian somatic nuclei into the germinal vesicles
isolated from Xenopus laevis oocytes. An elegant reporter
gene system in the somatic nuclei enabled him to detect
reactivation of stem-cell genes as their transcripts contained
a high-affinity binding site for a protein tagged with yellow
fluorescent protein. Gene reactivation was associated with an
of linker histone H1 mobility. Jullien showed that
accumulation of the oocyte H1 in the transplanted nuclei is a
critical step required for nuclear reprogramming.
Gain of totipotency, a characteristic of the germ line, involves
genome-wide erasure of DNA methylation. To uncover the
mechanisms that govern this reprogramming, Petra Hajkova
(University of Cambridge, UK) investigated chromatin
dynamics in developing mouse germ cells. She introduced the
concept of two-step epigenetic reprogramming in the germ-
cell lineage. Previous work had established that DNA
demethylation occurs in primordial germ cells (PGCs) after
they migrate to the gonads, at around embryonic day (E) 11.5.
Hajkova observed distinct chromatin changes several days
before DNA demethylation. Immunostaining of PGCs
isolated around E8.5 revealed a signature pattern of histone
modification reminiscent of pluripotency. These cells show
loss of methylation on H3K9, enrichment of acetylation
marks and tri-methylation of H3K27 as well as symmetrical
methylation of arginine 3 on H2A and H4. The second step of
remodeling occurs once the PGCs have reached the gonads
and involves transient chromatin decondensation, alterations
in the location of heterochromatin-associated proteins and in
the nuclear architecture. Most striking was the extensive
erasure of numerous histone modifications.
Hajkova argued that the mechanism for this is likely to
involve large-scale eviction of histones from chromatin and
histone replacement. In support of this attractive model she
showed that chaperones implicated in histone exchange
accumulate in PGCs during the second wave of repro-
gramming. Likewise, during this period an exchange of
histone variants was evident, including the loss of H2AZ as
well as H1. The onset of DNA demethylation precedes histone
replacement at the second step of chromatin remodeling,
suggesting that chromatin changes are largely the conse-
quence of DNA demethylation rather than a prerequisite.
This finding has exciting implications. Although it is known
that this erasure of DNA methylation occurs in the absence of
DNA replication and is apparently an active process,
clarification of the mechanism and identification of candidate
enzymes in mammals has remained a major challenge and a
hotly debated topic. Results from plants have implicated the
DNA repair pathway in DNA demethylation. Hajkova ended
her presentation with the speculation that reprogramming in
the mouse germ line may similarly entail a DNA-repair-
driven demethylation mechanism, which in turn could induce
chromatin changes and account for histone replacement. This
will be an interesting avenue for future studies and may
resolve a long-standing conundrum in the field.
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